Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trialMichel Seymour, Ruth E. Langley, Mahesh Parmar et al.|The Lancet|2011Cited by 420
Capecitabine (Cap) and oxaliplatin (Ox) in elderly and/or frail patients with metastatic colorectal cancer: The FOCUS2 trialMichel Seymour, Ruth E. Langley, Tim Maughan et al.|Journal of Clinical Oncology|2007Cited by 44
Chemotherapy for older patients with colorectal cancer – Authors' replyMichel Seymour, Tim Maughan, Lindsay C Thompson et al.|The Lancet|2011Cited by 0
P3.13C.02 A Plasma Proteomics-Based Model for Clinical Benefit Prediction in Small Cell Lung Cancer Patients Receiving ImmunotherapyDavid R. Gandara, M.A. Schneider, David P. Carbone et al.|Journal of Thoracic Oncology|2024Cited by 0